Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 368

1.

PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences.

Klaeser B, Mueller MD, Schmid RA, Guevara C, Krause T, Wiskirchen J.

Eur Radiol. 2009 Jul;19(7):1780-5. doi: 10.1007/s00330-009-1338-1. Epub 2009 Feb 24.

PMID:
19238391
[PubMed - indexed for MEDLINE]
2.

Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

Schaefer NG, Strobel K, Taverna C, Hany TF.

Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):60-7. Epub 2006 Sep 22.

PMID:
17021808
[PubMed - indexed for MEDLINE]
3.

Initial experience with FDG-PET/CT in the evaluation of breast cancer.

Tatsumi M, Cohade C, Mourtzikos KA, Fishman EK, Wahl RL.

Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):254-62. Epub 2005 Oct 29.

PMID:
16258765
[PubMed - indexed for MEDLINE]
4.

Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.

Schick V, Franzius C, Beyna T, Oei ML, Schnekenburger J, Weckesser M, Domschke W, Schober O, Heindel W, Pohle T, Juergens KU.

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1775-85. doi: 10.1007/s00259-008-0818-x. Epub 2008 May 15.

PMID:
18481063
[PubMed - indexed for MEDLINE]
5.

PET/CT for the staging and follow-up of patients with malignancies.

Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.

Eur J Radiol. 2009 Jun;70(3):382-92. doi: 10.1016/j.ejrad.2009.03.051. Epub 2009 Apr 29. Review.

PMID:
19406595
[PubMed - indexed for MEDLINE]
6.

Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?

Hain SF, O'Doherty MJ, Bingham J, Chinyama C, Smith MA.

Nucl Med Commun. 2003 Nov;24(11):1139-43.

PMID:
14569167
[PubMed - indexed for MEDLINE]
7.

18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.

Saif MW, Cornfeld D, Modarresifar H, Ojha B.

J Gastrointestin Liver Dis. 2008 Jun;17(2):173-8.

PMID:
18568138
[PubMed - indexed for MEDLINE]
Free Article
8.

The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.

Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.

J Nucl Med. 2009 Apr;50(4):506-12. doi: 10.2967/jnumed.108.056382. Epub 2009 Mar 16.

PMID:
19289438
[PubMed - indexed for MEDLINE]
Free Article
9.

Molecular positron emission tomography and PET/CT imaging in urological malignancies.

Powles T, Murray I, Brock C, Oliver T, Avril N.

Eur Urol. 2007 Jun;51(6):1511-20; discussion 1520-1. Epub 2007 Jan 23. Review.

PMID:
17275167
[PubMed - indexed for MEDLINE]
10.

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Fukasawa I, Inaba N, Suganuma N, Sugimura K.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1439-48. doi: 10.1007/s00259-008-0776-3. Epub 2008 Apr 17.

PMID:
18418592
[PubMed - indexed for MEDLINE]
11.

Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.

Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, Silverman DH, Ratib O, Czernin J.

J Nucl Med. 2005 Apr;46(4):603-7.

PMID:
15809482
[PubMed - indexed for MEDLINE]
Free Article
12.

The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, Panzavolta R, Crepaldi G, Rampin L, Facci E, Gava M, Banti E, Marano G.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1461-9. doi: 10.1016/j.ijrobp.2008.10.064. Epub 2009 May 4.

PMID:
19419820
[PubMed - indexed for MEDLINE]
13.

18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.

Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J.

Ann Nucl Med. 2008 Nov;22(9):795-802. doi: 10.1007/s12149-008-0186-4. Epub 2008 Nov 28.

PMID:
19039558
[PubMed - indexed for MEDLINE]
14.

Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.

Kuehl H, Rosenbaum-Krumme S, Veit-Haibach P, Stergar H, Forsting M, Bockisch A, Antoch G.

Nucl Med Commun. 2008 Jul;29(7):599-606. doi: 10.1097/MNM.0b013e3282f8144d.

PMID:
18528181
[PubMed - indexed for MEDLINE]
15.

The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

Beheshti M, Pöcher S, Vali R, Waldenberger P, Broinger G, Nader M, Kohlfürst S, Pirich C, Dralle H, Langsteger W.

Eur Radiol. 2009 Jun;19(6):1425-34. doi: 10.1007/s00330-008-1280-7. Epub 2009 Jan 21.

PMID:
19156423
[PubMed - indexed for MEDLINE]
16.

Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.

Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, Shiozaki H.

Ann Nucl Med. 2009 Jan;23(1):73-80. doi: 10.1007/s12149-008-0209-1. Epub 2009 Feb 11.

PMID:
19205841
[PubMed - indexed for MEDLINE]
17.

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.

Kim J, Lee J, Chang E, Kim S, Suh K, Sul J, Song I, Kim Y, Lee C.

World J Surg. 2009 May;33(5):943-9. doi: 10.1007/s00268-009-9955-z.

PMID:
19259728
[PubMed - indexed for MEDLINE]
18.

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

Alberini JL, Lerebours F, Wartski M, Fourme E, Le Stanc E, Gontier E, Madar O, Cherel P, Pecking AP.

Cancer. 2009 Nov 1;115(21):5038-47. doi: 10.1002/cncr.24534.

PMID:
19645022
[PubMed - indexed for MEDLINE]
Free Article
19.

Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.

Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.

Acta Radiol. 2009 Jul;50(6):638-44. doi: 10.1080/02841850902971255.

PMID:
19492198
[PubMed - indexed for MEDLINE]
20.

Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.

Goerres GW, Schuknecht B, Schmid DT, Stoeckli SJ, Hany TF.

Clin Imaging. 2008 Nov-Dec;32(6):431-7. doi: 10.1016/j.clinimag.2008.04.012.

PMID:
19006770
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk